Back
First Trust Nasdaq Pharmaceuticals ETF Vs. Virtus LifeSci Biotech Products ETF Industry Stock Comparison
Sell
41
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
27.74
Seasonality Move:
4.46%
Buy
67
BBP
Virtus LifeSci Biotech Products ETF
Last Price:
60.93
Seasonality Move:
5.11%
Sell
41
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.09. The Score for FTXH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Virtus LifeSci Biotech Products ETF (BBP)
is a Buy
Is Virtus LifeSci Biotech Products ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Products ETF [BBP] share price is $63.86. The Score for BBP is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- BBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBP Stock Price Chart
What is Virtus LifeSci Biotech Products ETF's stock price today?
-
The Virtus LifeSci Biotech Products ETF share price today is $63.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 48.86 | Sell |
Chaikin Money Flow: | 958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.64 - 28.74) | Sell |
Bollinger Bands (100): | (27.95 - 29.15) | Sell |
BBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 50.54 | Buy |
Chaikin Money Flow: | 493 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.09 - 66.21) | Sell |
Bollinger Bands (100): | (61.07 - 64.71) | Buy |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.64 | Buy |
20-day SMA: | 28.17 | Sell |
50-day SMA: | 28.51 | Sell |
200-day SMA: | 27.84 | Buy |
8-day EMA: | 27.79 | Buy |
20-day EMA: | 28.06 | Buy |
50-day EMA: | 28.33 | Sell |
200-day EMA: | 27.88 | Buy |
BBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.64 | Buy |
20-day SMA: | 64.42 | Sell |
50-day SMA: | 63.51 | Buy |
200-day SMA: | 59.8 | Buy |
8-day EMA: | 63.05 | Buy |
20-day EMA: | 63.7 | Buy |
50-day EMA: | 63.46 | Buy |
200-day EMA: | 60.23 | Buy |
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Products ETF Earnings Growth & BBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Virtus LifeSci Biotech Products ETF Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |